NCT04373265 2024-02-23Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)Corcept TherapeuticsPhase 1 Completed15 enrolled